Study of possible teratogenicity of bucloxic acid (804 CB).
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000633:toxicity*; D001835:Body Weight / Q000187:drug effects; D001842:Bone and Bones / Q000002:abnormalities; D003338:Corpus Luteum / Q000187:drug effects; D003510:Cyclohexanes / Q000633:toxicity; D005260:Female; D005298:Fertility / Q000187:drug effects; D005313:Fetal Death / Q000139:chemically induced; D005333:Fetus / Q000187:drug effects; D005865:Gestational Age; D006128:Growth / Q000187:drug effects; D007651:Keto Acids / Q000633:toxicity; D051379:Mice; D008815:Mice, Inbred Strains; D009929:Organ Size; D010654:Phenylbutyrates / Q000633:toxicity*; D010920:Placenta / Q000187:drug effects; D011247:Pregnancy; D011817:Rabbits; D051381:Rats; D012098:Reproduction / Q000187:drug effects; D013045:Species Specificity; D013550:Swimming; D013723:Teratogens / Q000633:toxicity*
D000893:Anti-Inflammatory Agents; D003510:Cyclohexanes; D007651:Keto Acids; D010654:Phenylbutyrates; D013723:Teratogens